Tweet This

Biosimilars User Fee Act

Creates an abbreviated licensure pathway for biologic products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biologic product. This pathway is provided in the part of the law known as the Biologics Price Competition and Innovation Act (BPCI Act).

Employer Retiree Coverage Subsidies

Eliminates the tax-deduction for employers who receive Medicare Part D retiree drug subsidy payments.